8-K - Enzon Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Securities Modification

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On January 30, 2026, Enzon Pharmaceuticals, Inc. (the “ Company ”) entered into the Seventh Amendment to the Section

Material Agreement

3.03

. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Description 4.1 Seventh Amendment to the Section 382 Rights Agreement, dated as of January

Securities Modification

Exhibits (2)

4.1

EXHIBIT 4.1

8-K

FORM 8-K